RNA Therapeutics Market By Type (mRNA, siRNA, miRNA, Antisense RNA, Aptamers, snRNA), By Application (Genetic Disorders, Cancer, Infectious Diseases, Cardiovascular Diseases, Neurological Disorders, Rare Diseases, Others), By Route of Administration (Intravenous, Intramuscular, Subcutaneous, Oral, Others), By End-User (Hospitals & Clinics, Research & Academic Institutes, Biopharmaceutical & Biotechnology Companies, Contract Research Organizations), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035
Published Date: Jun 2025 | Report ID: MI2917 | 220 Pages
Report Coverage:
By Type
- mRNA
- siRNA
- miRNA
- Antisense RNA
- Aptamers
- snRNA
By Application
- Genetic Disorders
- Cancer
- Infectious Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Rare Diseases
- Others
By Route of Administration
- Intravenous
- Intramuscular
- Subcutaneous
- Oral
- Others
By End User
- Hospitals & Clinics
- Research & Academic Institutes
- Biopharmaceutical & Biotechnology Companies
- Contract Research Organizations
By Region
North America
- U.S.
- Canada
Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
List of Companies:
- Moderna, Inc.
- BioNTech SE
- Alnylam Pharmaceuticals
- Ionis Pharmaceuticals
- CureVac AG
- Arcturus Therapeutics
- Translate Bio
- Arrowhead Pharmaceuticals
- Wave Life Sciences
- Dicerna Pharmaceuticals
- Silence Therapeutics
- Sarepta Therapeutics
- Regulus Therapeutics
- Eli Lilly and Company
- Pfizer Inc.
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.